Models and screening assays for drug discovery in osteoporosis
Authors:
- 16 September 2010
- journal article
- review article
- Published by Informa Healthcare in Expert Opinion on Drug Discovery
- Vol. 5 (12) , 1163-1174
Abstract
Importance of the field: Osteoporosis affects nearly 100 million people in Europe, Japan and the US, and the number is increasing due to aging of the population. Preclinical efficacy studies performed according to regulatory guidelines are large, long and expensive, and there is a need for guidance and recommendations on how to perform preliminary studies prior to the regulatory studies. Areas covered in this review: We review research models that can be used for preclinical efficacy testing of new drug candidates for osteoporosis. Our focus is on testing compounds targeted to directly decrease osteoclastic bone resorption or increase osteoblastic bone formation. What the reader will gain: We provide an overview of in vitro bone cell culture systems and osteoporosis animal models useful for preclinical efficacy studies and a step-by-step approach on how the most interesting compound can be selected from thousands of drug candidates. Different approaches for testing anti-catabolic and anabolic compounds ar...Keywords
This publication has 72 references indexed in Scilit:
- New Selective Estrogen Receptor Modulators (SERMs) in DevelopmentCurrent Osteoporosis Reports, 2010
- Sclerostin: Current Knowledge and Future PerspectivesCalcified Tissue International, 2010
- Wnt inhibitory factor 1 is epigenetically silenced in human osteosarcoma, and targeted disruption accelerates osteosarcomagenesis in miceJournal of Clinical Investigation, 2009
- Improved methods for testing antiresorptive compounds in human osteoclast culturesJournal of Bone and Mineral Metabolism, 2008
- Glucocorticoid‐induced bone loss in mice can be reversed by the actions of parathyroid hormone and risedronate on different pathways for bone formation and mineralizationArthritis & Rheumatism, 2008
- Building bone to reverse osteoporosis and repair fracturesJournal of Clinical Investigation, 2008
- Osteoclasts secrete non-bone derived signals that induce bone formationBiochemical and Biophysical Research Communications, 2008
- Estrogen protects primary osteocytes against glucocorticoid-induced apoptosisApoptosis, 2005
- Biochemical Markers of Bone Metabolism and Prediction of Fracture in Elderly WomenJournal of Bone and Mineral Research, 2004
- Development of the osteoblast phenotype in primary human osteoblasts in culture: Comparison with rat calvarial cells in osteoblast differentiationJournal of Cellular Biochemistry, 1999